Stay updated on Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, indicating a CMS/content update. This change does not modify the study details or related information.
    Difference
    0.1%
    Check dated 2026-08-29T20:52:58.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The study page now includes posted results and related outcomes, biomarker analyses, and access to the protocol and statistical analysis plan, reflecting the updated results status of the trial.
    Difference
    2%
    Check dated 2026-08-22T20:43:54.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added. A large block of non-core footer and indexing terms was removed from the page, simplifying the display without changing the core study details.
    Difference
    18%
    Check dated 2026-08-08T18:14:26.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.6.4 was applied to the page. This is a back-end update and does not modify the study information, eligibility criteria, or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-07-25T11:33:26.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a maintenance update to the page's underlying software rather than changes to study details.
    Difference
    0.1%
    Check dated 2026-07-03T23:50:24.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, signaling a routine maintenance update to the study page. No content changes to the study details or eligibility criteria are indicated by this revision.
    Difference
    0.1%
    Check dated 2026-06-26T23:11:31.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.